At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 3, 2026 at 19:00 ET
Entrada Therapeutics President & COO Nathan J. Dowden sold a total of 15,010 shares in the past week for approximately $195,771 in open-market transactions. The sales represent a modest insider divestment by a single C-suite executive.
- President & COO Nathan J. Dowden sold 15,010 shares over two days (11,894 shares on 2026-03-10 at $13.0476; 3,116 shares on 2026-03-09 at $13.024).
- Total proceeds from the sales were $195,770.93.
- All transactions were open-market sales (Form 4 codes 'S').
- No other insiders participated in this cluster.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access